Patient Transfer Monitoring System in Hospital Using Mobile IoT Technology

March 6, 2019 updated by: Chang-Min Choi, Asan Medical Center

Demonstration and Multi-center Verification of the Patient Transfer Monitoring System in Hospital Using Mobile IoT Technology

This trial is multi-center prospective study to develop Patient Transfer Monitoring system using mobile lot network and the Risk Factor Detection System and apply to real In-Hospital Patients and verify the efficacy.

Study Overview

Status

Completed

Conditions

Detailed Description

Hospitalized patients who need transfer for a diagnostic examination or rehabilitation therapy during hospitalization, and have a risk of hypoxemia during transfer will be enrolled in this trial. The subjects will be provided with a portable oximeter and a smart-phone which application for monitoring is installed, and oxygen saturation and pulse rate will be checked in real time during transfer. The collected data will be transferred to cloud system via Iot network, and the transmitted data will be monitored in real time via monitoring equipment in the (Patient-hospitalized) ward. If there is a risk, the alarm system is activated so that the medical team is able to check risk factor and manage it immediately.

All the risk factors and severity will be collected during transfer, also these are checked whether the monitoring system and the data transmission system work properly or not, the time from detecting risk factor to medical response, the composition of medical staffs who responding to alarmed risk factors and improvement of the subjects.

Pilot study will be conducted with 20 subjects in Asan medical center. In pilot study, monitoring machines (HR, SpO2 monitor) commonly used in wards or hospitals will be used to verify the stability of oximeter used in this study and the developed risk detection system.

Study Type

Interventional

Enrollment (Actual)

143

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Daejeon, Korea, Republic of, 35262
        • DAVINCI hospital
      • Seoul, Korea, Republic of, 05505
        • Asan Medical Center
      • Seoul, Korea, Republic of, 02447
        • Kyunghee University Medical Center
      • Wonju, Korea, Republic of, 26426
        • Wonju Severance Christian Hospital
    • Gangwon-Do
      • Chuncheon, Gangwon-Do, Korea, Republic of, 24289
        • Kangwon National Univeristy Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A hospitalized patients in pulmonology department or rehabilitation hospital who have a risk of decreasing oxygen saturation
  • A patients who require transfer in the hospital for a diagnostic examination or rehabilitation therapy during hospitalization
  • Patients who need oxygen saturation monitoring according to the investigator's judgment
  • Patients who voluntarily agree to study participation and provide written informed consent form

Exclusion Criteria:

  • Patients who don't agree with the study procedure or are uncooperative
  • Repeated monitoring of the same patient who already registered in the tiral

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patient Transfer Monitoring System
The subjects will be provided with portable oximeter and smart-phone which application for monitoring is installed, and the transmitted data will be monitored in real time via monitoring equipment in the (Patient-hospitalized) ward.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
frequency of risk factors which are detected during transfer
Time Frame: from the beginning to immediately after the end of the patient transfer
from the beginning to immediately after the end of the patient transfer
severity of risk factors which are detected during transfer
Time Frame: from the beginning to immediately after the end of the patient transfer
The severity is assessed as mild(risk factor was resolved without medical staff), moderate(resolved by medical staffs, but returned to the ward), and severe(not resolved by medical staffs, needs other method such as CPCR call, invasive intervention).
from the beginning to immediately after the end of the patient transfer
reason of decreased oxygen saturation
Time Frame: from the beginning to immediately after the end of the patient transfer
from the beginning to immediately after the end of the patient transfer
duration of decreased oxygen saturation
Time Frame: from the beginning to immediately after the end of the patient transfer
from the beginning to immediately after the end of the patient transfer
change from baseline in Oxygen saturation
Time Frame: from the beginning to immediately after the end of the patient transfer
from the beginning to immediately after the end of the patient transfer
the time from detecting risk factor to medical response
Time Frame: from the beginning to immediately after the end of the patient transfer
from the beginning to immediately after the end of the patient transfer
Death
Time Frame: from admission to discharge, up to 8 months
from admission to discharge, up to 8 months
admission to intensive care units
Time Frame: from admission to discharge, up to 8 months
from admission to discharge, up to 8 months
Adverse events related to the study
Time Frame: from the beginning to immediately after the end of the patient transfer
from the beginning to immediately after the end of the patient transfer
medical staffs who managed the alarmed event during transfer
Time Frame: from the beginning to immediately after the end of the patient transfer
from the beginning to immediately after the end of the patient transfer

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chang-Min Choi, MD, Ph. D, Asan Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 16, 2018

Primary Completion (Actual)

November 28, 2018

Study Completion (Actual)

December 28, 2018

Study Registration Dates

First Submitted

May 27, 2018

First Submitted That Met QC Criteria

June 28, 2018

First Posted (Actual)

June 29, 2018

Study Record Updates

Last Update Posted (Actual)

March 8, 2019

Last Update Submitted That Met QC Criteria

March 6, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • C2018-00554

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe